| Financial Year |
March 31 2023 |
| Monetary Funds |
773,151,801.27 |
| Held-for-trading Financial Assets |
101,226,079.86 |
| Notes Receivable |
389,817,602.61 |
| Accounts Receivable |
1,754,123,583.90 |
| Advances to Suppliers |
170,015,413.42 |
| Other Receivables |
65,893,370.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,308,829,804.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,820,056.23 |
| Total Current Assets |
5,291,600,040.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,582,286.10 |
| Long-term Equity Investment |
56,905,651.58 |
| Investment Properties |
398,225,305.47 |
| Fixed Assetes |
1,389,603,343.96 |
| Under-construction Projects |
169,053,592.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,856,873.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,650,602.68 |
| Deferred Income Tax Assets |
79,806,491.83 |
| Other Non-Current Assets |
75,899,971.29 |
| Sub-Total of Non-Current Assets |
2,477,149,454.77 |
| Total Assets |
7,768,749,495.12 |
| Short-Term Loans |
554,332,442.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,224,278,133.90 |
| Accounts Payable |
476,470,425.72 |
| Accounts Received In Advance |
9,397,052.02 |
| Employee Compensation Payable |
77,394,351.32 |
| Taxes Payable |
23,756,197.49 |
| Interest Payable |
-- |
| Dividend Payable |
9,199,328.60 |
| Other payables |
294,746,427.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,446,479.84 |
| Other Current Liabilities |
42,696,754.96 |
| Sub-Total of Current Liabilities |
3,133,476,211.67 |
| Long-term Loans |
411,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
548,329.31 |
| Deferred Income Tax Liabilities |
28,016,732.81 |
| Other Non-Current Liabilities |
4,898,139.25 |
| Sub-Total of Non-Current Liabilities |
529,045,784.36 |
| Total Liabilities |
3,662,521,996.03 |
| Paid-In Capital(Or Share Stock) |
733,941,062.00 |
| Capital Surplus |
1,394,216,168.96 |
| Surplus Reserve |
236,783,752.29 |
| LESS:Treasury Stock |
1,240,140.00 |
| Undistributed Profits |
1,343,866,754.06 |
| Minority Stockholder's Interest |
364,802,264.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,741,425,234.43 |
| Owner's Equity（Stockholder's Equity） |
4,106,227,499.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,768,749,495.12 |
